Development and Validation of a Rapid HPLC Assay for the Simultaneous Determination of Three Psychoanaleptic Drugs in Pharmaceutical Formulations
Authors:
- 29 January 2008
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 31 (5) , 722-732
Abstract
Atomoxetine, venlafaxine, and fluoxetine are classified as psychoanaleptics. While atomoxetine is used for the treatment of attention deficit/hyperactivity disorder (ADHD), the other two are for depressive disorders. A simple, rapid, isocratic, high performance liquid chromatographic (HPLC) method has been developed for the determination of atomoxetine, venlafaxine, and fluoxetine in pharmaceutical products. The HPLC method involves separation by reversed phase HPLC on a Nova‐Pak C18 column (15 cm×3.9 mm id) using acetonitrile‐potassium dihydrogen phosphate buffer (0.05 M adjusted to pH 3.0 with phosphoric acid) (45:55 v/v) as the mobile phase, at a flow rate of 0.8 mL/min at room temperature (25°C), using UV detection at 226 nm. The method was validated for specificity, linearity, precision, accuracy, limit of detection (LOD), limit of quantitation (LOQ), and robustness. The excipients present in the formulations do not interfere with the assay procedure. The developed method was successfully applied to determine atomoxetine, venlafaxine, and fluoxetine in pharmaceutical formulations.Keywords
This publication has 16 references indexed in Scilit:
- Assay validation for three antidepressants in pharmaceutical formulations: Practical approach using capillary gas chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2005
- Development of a capillary gas chromatographic procedureAnalytica Chimica Acta, 2004
- AtomoxetinePediatric Drugs, 2003
- Sensitive and rapid high-performance liquid chromatographic method for simultaneous determination of antidepressants in pharmaceutical formulationsChromatographia, 2002
- Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulationsJournal of Pharmaceutical and Biomedical Analysis, 2002
- HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY AND DRUG DISSOLUTION STUDIES OF FLUOXETINE HYDROCHLORIDE IN CAPSULE FORMULATIONSJournal of Liquid Chromatography & Related Technologies, 2000
- Analytical methods for the quality control of Prozac® capsulesJournal of Pharmaceutical and Biomedical Analysis, 1998
- Treatment of dysthymic disorderDepression and Anxiety, 1998
- Rapid onset of action of venlafaxineInternational Clinical Psychopharmacology, 1995
- Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sitesNeuroscience Letters, 1993